Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NOX66 and Palliative Radiotherapy in Patients With Late-Stage Prostate Cancer - a Phase 1b Proof of Concept and Dose Confirmation Study

NCT03307629 is registered in ClinicalTrials.gov with Noxopharm Limited as lead sponsor.

NCT NCT03307629
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03307629 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NOX66 and Palliative Radiotherapy in Patients With Late-Stage Prostate Cancer - a Phase 1b Proof of Concept and Dose Confirmation Study
Lead sponsor
Noxopharm Limited
Phase
Phase 1
Overall status
Completed
Start date
November 1, 2017
Completion date
September 15, 2020
Enrollment
25 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

cancer